Srinagar, Apr 4: Advanced neurotechnology services at Medanta – The Medicity are emerging as a key healthcare avenue for patients from Jammu and Kashmir, highlighting the growing business potential of specialised medical services catering to underserved regions.
Deep Brain Stimulation (DBS), or “brain pacemaker surgery,” led by Dr. Anirban Deep Banerjee, is positioning Medanta as a major destination for treatment of advanced neurological disorders such as Parkinson’s disease, dystonia, epilepsy, essential tremor, and OCD.
The hospital’s adoption of advanced imaging, AI-guided brain targeting, and real-time neurostimulation reflects a broader shift towards high-end, technology-driven healthcare services. These innovations not only improve clinical outcomes but also expand Medanta’s reach to patients from regions like Jammu and Kashmir, where access to such specialised care remains limited.
Healthcare experts note that neurological disorders account for nearly 10% of India’s disease burden, creating a growing demand for advanced interventions like DBS. Medanta’s integration of remote programming and adaptive DBS technology also reduces follow-up travel, making treatment more accessible and cost-efficient for outstation patients.
Successful cases from J&K, including patients from Jammu and Udhampur, underline both the clinical impact and the expanding referral base, positioning DBS therapy as a significant contributor to the evolving medical value travel ecosystem in India.
